{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:05:10Z","timestamp":1789733110793,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2025111003"],"award-info":[{"award-number":["H2025111003"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Science Research Project of Hebei","award":["20250275"],"award-info":[{"award-number":["20250275"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04489-y","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:03:42Z","timestamp":1785222222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stress-driven reprogramming of plasmacytoid dendritic cells in intrahepatic cholangiocarcinoma defines a reversible targetable immunosuppressive state"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9659-8881","authenticated-orcid":false,"given":"Mei-Ru","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Mei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suping","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Chao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Bo","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3096-1990","authenticated-orcid":false,"given":"Li-Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"4489_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","volume":"34","author":"A Vogel","year":"2023","unstructured":"Vogel A, Bridgewater J, Edeline J, et al. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:127\u201340. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.506.","journal-title":"Ann Oncol"},{"key":"4489_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557\u201388. https:\/\/doi.org\/10.1038\/s41575-020-0310-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4489_CR3","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/hep.30289","volume":"69","author":"AE Sirica","year":"2019","unstructured":"Sirica AE, Gores GJ, Groopman JD, et al. Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances. Hepatology. 2019;69:1803\u201315. https:\/\/doi.org\/10.1002\/hep.30289.","journal-title":"Hepatology"},{"key":"4489_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/jcmm.13953","volume":"23","author":"Z Chen","year":"2019","unstructured":"Chen Z, Guo P, Xie X, et al. The role of tumour microenvironment: a new vision for cholangiocarcinoma. J Cell Mol Med. 2019;23:59\u201369. https:\/\/doi.org\/10.1111\/jcmm.13953.","journal-title":"J Cell Mol Med"},{"key":"4489_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/13543784.2021.1865308","volume":"30","author":"J Wang","year":"2021","unstructured":"Wang J, Ilyas S. Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy. Expert Opin Investig Drugs. 2021;30:429\u201338. https:\/\/doi.org\/10.1080\/13543784.2021.1865308.","journal-title":"Expert Opin Investig Drugs"},{"key":"4489_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","volume":"15","author":"M Swiecki","year":"2015","unstructured":"Swiecki M, Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015;15:471\u201385. https:\/\/doi.org\/10.1038\/nri3865.","journal-title":"Nat Rev Immunol"},{"key":"4489_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.coi.2020.08.001","volume":"66","author":"TT Greene","year":"2020","unstructured":"Greene TT, Jo Y, Zuniga EI. Infection and cancer suppress pDC derived IFN-I. Curr Opin Immunol. 2020;66:114\u201322. https:\/\/doi.org\/10.1016\/j.coi.2020.08.001.","journal-title":"Curr Opin Immunol"},{"key":"4489_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13046-024-03121-9","volume":"43","author":"M Monti","year":"2024","unstructured":"Monti M, Ferrari G, Gazzurelli L, et al. Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling. J Exp Clin Cancer Res. 2024;43:196. https:\/\/doi.org\/10.1186\/s13046-024-03121-9.","journal-title":"J Exp Clin Cancer Res"},{"key":"4489_CR9","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1158\/0008-5472.CAN-11-3468","volume":"72","author":"V Sisirak","year":"2012","unstructured":"Sisirak V, Faget J, Gobert M, et al. Impaired IFN-\u03b1 Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression. Cancer Res. 2012;72:5188\u201397. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3468.","journal-title":"Cancer Res"},{"key":"4489_CR10","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1158\/0008-5472.CAN-12-2271","volume":"72","author":"C Conrad","year":"2012","unstructured":"Conrad C, Gregorio J, Wang Y-H, et al. Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3\u2009+\u2009T-Regulatory Cells. Cancer Res. 2012;72:5240\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2271.","journal-title":"Cancer Res"},{"key":"4489_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.archoralbio.2018.06.006","volume":"93","author":"N Han","year":"2018","unstructured":"Han N, Zhang Z, Jv H, et al. Culture supernatants of oral cancer cells induce impaired IFN-\u03b1 production of pDCs partly through the down-regulation of TLR-9 expression. Arch Oral Biol. 2018;93:141\u20138. https:\/\/doi.org\/10.1016\/j.archoralbio.2018.06.006.","journal-title":"Arch Oral Biol"},{"key":"4489_CR12","doi-asserted-by":"publisher","unstructured":"Butsch R, waelti SL, Schaerer S, et al. Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma. Leuk Lymphoma. 2011,52(7):1230-1238. https:\/\/doi.org\/10.3109\/10428194.2011.569619.","DOI":"10.3109\/10428194.2011.569619"},{"key":"4489_CR13","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41422-020-0374-x","volume":"30","author":"Y-P Chen","year":"2020","unstructured":"Chen Y-P, Yin J-H, Li W-F, et al. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Res. 2020;30:1024\u201342. https:\/\/doi.org\/10.1038\/s41422-020-0374-x.","journal-title":"Cell Res"},{"key":"4489_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41588-020-0631-4","volume":"52","author":"J Morrison","year":"2020","unstructured":"Morrison J, Knoblauch N, Marcus JH, et al. Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics. Nat Genet. 2020;52:740\u20137. https:\/\/doi.org\/10.1038\/s41588-020-0631-4.","journal-title":"Nat Genet"},{"key":"4489_CR15","doi-asserted-by":"publisher","unstructured":"Mv JB H. Meta-analysis and Mendelian randomization: A review. Res Synth Methods. 2019;10. https:\/\/doi.org\/10.1002\/jrsm.1346.","DOI":"10.1002\/jrsm.1346"},{"key":"4489_CR16","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","volume":"53","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zheng Z, Fang H, Yang J. A generalized linear mixed model association tool for biobank-scale data. Nat Genet. 2021;53:1616\u201321. https:\/\/doi.org\/10.1038\/s41588-021-00954-4.","journal-title":"Nat Genet"},{"key":"4489_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036\u201345. https:\/\/doi.org\/10.1038\/s41588-020-0684-4.","journal-title":"Nat Genet"},{"key":"4489_CR18","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/ng.3368","volume":"47","author":"C Sidore","year":"2015","unstructured":"Sidore C, Busonero F, Maschio A, et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat Genet. 2015;47:1272\u201381. https:\/\/doi.org\/10.1038\/ng.3368.","journal-title":"Nat Genet"},{"key":"4489_CR19","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.joca.2021.08.003","volume":"29","author":"X-H Yu","year":"2021","unstructured":"Yu X-H, Yang Y-Q, Cao R-R, et al. The causal role of gut microbiota in development of osteoarthritis. Osteoarthr Cartil. 2021;29:1741\u201350. https:\/\/doi.org\/10.1016\/j.joca.2021.08.003.","journal-title":"Osteoarthr Cartil"},{"key":"4489_CR20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s12072-019-09954-3","volume":"13","author":"KS Ahn","year":"2019","unstructured":"Ahn KS, O\u2019Brien D, Kang YN, et al. Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach. Hepatol Int. 2019;13:490\u2013500. https:\/\/doi.org\/10.1007\/s12072-019-09954-3.","journal-title":"Hepatol Int"},{"key":"4489_CR21","doi-asserted-by":"publisher","first-page":"104154","DOI":"10.1016\/j.ebiom.2022.104154","volume":"82","author":"SC Larsson","year":"2022","unstructured":"Larsson SC, Burgess S. Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies. eBioMedicine. 2022;82:104154. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104154.","journal-title":"eBioMedicine"},{"key":"4489_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","volume":"72","author":"O Clements","year":"2020","unstructured":"Clements O, Eliahoo J, Kim JU, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. J Hepatol. 2020;72:95\u2013103. https:\/\/doi.org\/10.1016\/j.jhep.2019.09.007.","journal-title":"J Hepatol"},{"key":"4489_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/hep.28529","volume":"64","author":"J Choi","year":"2016","unstructured":"Choi J, Ghoz HM, Peeraphatdit T, et al. Aspirin use and the risk of cholangiocarcinoma. Hepatology. 2016;64:785\u201396. https:\/\/doi.org\/10.1002\/hep.28529.","journal-title":"Hepatology"},{"key":"4489_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12264-024-01325-9","volume":"41","author":"M Huang","year":"2025","unstructured":"Huang M, Bao J, Tao X, et al. Ventral Hippocampal CA1 GADD45B Regulates Susceptibility to Social Stress by Influencing NMDA Receptor-Mediated Synaptic Plasticity. Neurosci Bull. 2025;41:406\u201320. https:\/\/doi.org\/10.1007\/s12264-024-01325-9.","journal-title":"Neurosci Bull"},{"key":"4489_CR25","doi-asserted-by":"publisher","unstructured":"Yang R, Lu Y, Yin N, Faiola F. Transcriptomic Integration Analyses Uncover Common Bisphenol A Effects Across Species and Tissues Primarily Mediated by Disruption of JUN\/FOS, EGFR, ER, PPARG, and P53 Pathways. Environ Sci Technol. 2023. https:\/\/doi.org\/10.1021\/acs.est.3c02016.","DOI":"10.1021\/acs.est.3c02016"},{"key":"4489_CR26","doi-asserted-by":"publisher","first-page":"117917","DOI":"10.1016\/j.biopha.2025.117917","volume":"184","author":"A Schiavon","year":"2025","unstructured":"Schiavon A, Saba L, Evaristo C, et al. Mitotane activates ATF4\/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells. Biomed Pharmacother. 2025;184:117917. https:\/\/doi.org\/10.1016\/j.biopha.2025.117917.","journal-title":"Biomed Pharmacother"},{"key":"4489_CR27","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1016\/j.molcel.2021.09.016","volume":"81","author":"H Guo","year":"2021","unstructured":"Guo H, Golczer G, Wittner BS, et al. NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer. Mol Cell. 2021;81:4041\u2013e405815. https:\/\/doi.org\/10.1016\/j.molcel.2021.09.016.","journal-title":"Mol Cell"},{"key":"4489_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/leu.2015.11","volume":"29","author":"A Ray","year":"2015","unstructured":"Ray A, Das DS, Song Y, et al. Targeting PD1\u2013PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells. Leukemia. 2015;29:1441\u20134. https:\/\/doi.org\/10.1038\/leu.2015.11.","journal-title":"Leukemia"},{"key":"4489_CR29","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1158\/0008-5472.CAN-22-1199","volume":"82","author":"L Pang","year":"2022","unstructured":"Pang L, Yeung OWH, Ng KTP, et al. Postoperative Plasmacytoid Dendritic Cells Secrete IFN\u03b1 to Promote Recruitment of Myeloid-Derived Suppressor Cells and Drive Hepatocellular Carcinoma Recurrence. Cancer Res. 2022;82:4206\u201318. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1199.","journal-title":"Cancer Res"},{"key":"4489_CR30","doi-asserted-by":"publisher","first-page":"e001813","DOI":"10.1136\/jitc-2020-001813","volume":"9","author":"M Kie\u00dfler","year":"2021","unstructured":"Kie\u00dfler M, Plesca I, Sommer U, et al. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer. J Immunother Cancer. 2021;9:e001813. https:\/\/doi.org\/10.1136\/jitc-2020-001813.","journal-title":"J Immunother Cancer"},{"key":"4489_CR31","doi-asserted-by":"publisher","first-page":"e006714","DOI":"10.1136\/jitc-2023-006714","volume":"11","author":"L Fernandez-Rodriguez","year":"2023","unstructured":"Fernandez-Rodriguez L, Cianciaruso C, Bill R, et al. Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity. J Immunother Cancer. 2023;11:e006714. https:\/\/doi.org\/10.1136\/jitc-2023-006714.","journal-title":"J Immunother Cancer"},{"key":"4489_CR32","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1158\/0008-5472.CAN-21-1545","volume":"81","author":"JA Zundell","year":"2021","unstructured":"Zundell JA, Fukumoto T, Lin J, et al. Targeting the IRE1\u03b1\/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A-Mutant Ovarian Cancers. Cancer Res. 2021;81:5325\u201335. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1545.","journal-title":"Cancer Res"},{"key":"4489_CR33","doi-asserted-by":"publisher","first-page":"124145","DOI":"10.1016\/j.envpol.2024.124145","volume":"352","author":"M Li","year":"2024","unstructured":"Li M, Tang S, Velkov T, et al. Copper exposure induces mitochondrial dysfunction and hepatotoxicity via the induction of oxidative stress and PERK\/ATF4 -mediated endoplasmic reticulum stress. Environ Pollut. 2024;352:124145. https:\/\/doi.org\/10.1016\/j.envpol.2024.124145.","journal-title":"Environ Pollut"},{"key":"4489_CR34","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.3390\/ijms23052642","volume":"23","author":"X Huang","year":"2022","unstructured":"Huang X, Hao J, Tan YQ, et al. CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives. Int J Mol Sci. 2022;23:2642. https:\/\/doi.org\/10.3390\/ijms23052642.","journal-title":"Int J Mol Sci"},{"key":"4489_CR35","doi-asserted-by":"publisher","unstructured":"Chaudhary V, Ah Kioon MD, Hwang S-M, et al. Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses. J Exp Med. 2022;219. https:\/\/doi.org\/10.1084\/jem.20221085.","DOI":"10.1084\/jem.20221085"},{"key":"4489_CR36","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.1038\/s41467-024-53039-1","volume":"15","author":"B Unal","year":"2024","unstructured":"Unal B, Kuzu OF, Jin Y, et al. Targeting IRE1\u03b1 reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer. Nat Commun. 2024;15:8895. https:\/\/doi.org\/10.1038\/s41467-024-53039-1.","journal-title":"Nat Commun"},{"key":"4489_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12964-024-01470-8","volume":"22","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang S, Wang X, et al. Tumorous IRE1\u03b1 facilitates CD8\u2009+\u2009T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma. Cell Commun Signal. 2024;22:83. https:\/\/doi.org\/10.1186\/s12964-024-01470-8.","journal-title":"Cell Commun Signal"},{"key":"4489_CR38","doi-asserted-by":"publisher","first-page":"e202111068","DOI":"10.1083\/jcb.202111068","volume":"221","author":"O Guttman","year":"2022","unstructured":"Guttman O, Le Thomas A, Marsters S, et al. Antigen-derived peptides engage the ER stress sensor IRE1\u03b1 to curb dendritic cell cross-presentation. J Cell Biol. 2022;221:e202111068. https:\/\/doi.org\/10.1083\/jcb.202111068.","journal-title":"J Cell Biol"},{"key":"4489_CR39","doi-asserted-by":"publisher","unstructured":"Flores-Santiba\u00f1ez F, Rennen S, Fern\u00e1ndez D, et al. Nuanced role for dendritic cell intrinsic IRE1 RNase in the regulation of antitumor adaptive immunity. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1209588.","DOI":"10.3389\/fimmu.2023.1209588"},{"key":"4489_CR40","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/s12935-020-01676-z","volume":"20","author":"Z-Q Hu","year":"2020","unstructured":"Hu Z-Q, Zhou Z-J, Luo C-B, et al. Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection. Cancer Cell Int. 2020;20:582. https:\/\/doi.org\/10.1186\/s12935-020-01676-z.","journal-title":"Cancer Cell Int"},{"key":"4489_CR41","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/17520363.2024.2385297","volume":"18","author":"Y Lou","year":"2024","unstructured":"Lou Y, Chen Y, Guo K, et al. Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies. Biomark Med. 2024;18:703\u201315. https:\/\/doi.org\/10.1080\/17520363.2024.2385297.","journal-title":"Biomark Med"},{"key":"4489_CR42","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/oncolo\/oyac139","volume":"27","author":"DC Madoff","year":"2022","unstructured":"Madoff DC, Abi-Jaoudeh N, Braxton D, et al. An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma. Oncologist. 2022;27:884\u201391. https:\/\/doi.org\/10.1093\/oncolo\/oyac139.","journal-title":"Oncologist"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04489-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:21:05Z","timestamp":1789730465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04489-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4489"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04489-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received approval from the Research Ethics Committee of the Second Hospital of Hebei Medical University (Approval No. 2024-R474) and Hengshui People\u2019s Hospital (Approval No. 2024154-1) for the research involving human samples. Written informed consent was obtained from all patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"376"}}